Article citationsMore>>

Markert, J.M., Razdan, S.N., Kuo, H.-C., et al. (2014) A Phase I Trial of Oncolytic HSV-1, G207, Given in Combination with Radiation for Recurrent GBM demonstrates Safety and Radiographic Responses. Molecular Therapy, 22, 1048-1055.

has been cited by the following article:

• TITLE: Maximizing Function and Quality of Life of Patients with Glioblastoma after Surgical Resection: A Review of Current Literature

  AUTHORS: Matthew Smith-Cohn, Zhijian Chen, David Peereboom, Glen Stevens

  KEYWORDS: Palliative, Glioblastoma, Steroids, Seizure, Rehabilitation, Myopathy

  JOURNAL NAME: Journal of Cancer Therapy, Vol.7 No.12, November 4, 2016

  ABSTRACT: After surgical resection, patients with glioblastoma require many aspects of care to maximize function and quality of life. Patients face a multitude of hurdles that require the expertise of a variety of specialists. Here we will review the current literature on management of glioblastoma patients after surgical resection.